Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $166.33 million. The enterprise value is $170.43 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 23.30 million shares outstanding. The number of shares has increased by 12.95% in one year.
| Current Share Class | 17.30M |
| Shares Outstanding | 23.30M |
| Shares Change (YoY) | +12.95% |
| Shares Change (QoQ) | +6.10% |
| Owned by Insiders (%) | 12.47% |
| Owned by Institutions (%) | 20.59% |
| Float | 11.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 81.31 |
| PS Ratio | 2.39 |
| Forward PS | 2.82 |
| PB Ratio | 6.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.34 |
| Quick Ratio | 0.97 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.27 |
Financial Efficiency
Return on equity (ROE) is -48.14% and return on invested capital (ROIC) is -11.16%.
| Return on Equity (ROE) | -48.14% |
| Return on Assets (ROA) | -5.70% |
| Return on Invested Capital (ROIC) | -11.16% |
| Return on Capital Employed (ROCE) | -15.45% |
| Revenue Per Employee | $1.37M |
| Profits Per Employee | -$202,512 |
| Employee Count | 41 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, Journey Medical has paid $61,000 in taxes.
| Income Tax | 61,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.91% in the last 52 weeks. The beta is 0.88, so Journey Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +38.91% |
| 50-Day Moving Average | 7.03 |
| 200-Day Moving Average | 5.72 |
| Relative Strength Index (RSI) | 53.71 |
| Average Volume (20 Days) | 179,680 |
Short Selling Information
The latest short interest is 549,561, so 2.36% of the outstanding shares have been sold short.
| Short Interest | 549,561 |
| Short Previous Month | 393,717 |
| Short % of Shares Out | 2.36% |
| Short % of Float | 4.98% |
| Short Ratio (days to cover) | 4.77 |
Income Statement
In the last 12 months, Journey Medical had revenue of $56.24 million and -$8.30 million in losses. Loss per share was -$0.39.
| Revenue | 56.24M |
| Gross Profit | 36.58M |
| Operating Income | -6.91M |
| Pretax Income | -3.94M |
| Net Income | -8.30M |
| EBITDA | -3.24M |
| EBIT | -6.91M |
| Loss Per Share | -$0.39 |
Full Income StatementBalance Sheet
The company has $21.07 million in cash and $25.17 million in debt, giving a net cash position of -$4.10 million or -$0.18 per share.
| Cash & Cash Equivalents | 21.07M |
| Total Debt | 25.17M |
| Net Cash | -4.10M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | 21.54M |
| Book Value Per Share | 0.93 |
| Working Capital | 13.76M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.94M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.94M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
Gross margin is 65.03%, with operating and profit margins of -12.29% and -14.76%.
| Gross Margin | 65.03% |
| Operating Margin | -12.29% |
| Pretax Margin | -14.65% |
| Profit Margin | -14.76% |
| EBITDA Margin | -5.75% |
| EBIT Margin | -12.29% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.95% |
| Shareholder Yield | -12.95% |
| Earnings Yield | -4.99% |
| FCF Yield | -4.17% |
Analyst Forecast
The average price target for Journey Medical is $10.00, which is 40.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 40.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 0.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 2 |